127 related articles for article (PubMed ID: 12148890)
1. Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphoma.
Lossos IS; Thorstenson YR; Wayne TL; Oefner PJ; Levy R; Chu G
Leuk Lymphoma; 2002 May; 43(5):1079-85. PubMed ID: 12148890
[TBL] [Abstract][Full Text] [Related]
2. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
[TBL] [Abstract][Full Text] [Related]
3. Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma.
Do B; Lossos IS; Thorstenson Y; Oefner PJ; Levy R
Leuk Lymphoma; 2003 Aug; 44(8):1317-23. PubMed ID: 12952224
[TBL] [Abstract][Full Text] [Related]
4. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene.
Lossos IS; Levy R
Blood; 2000 Jul; 96(2):635-9. PubMed ID: 10887128
[TBL] [Abstract][Full Text] [Related]
5. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin.
Kim SH; Cheong JW; Park KH; Kim TS; Yang WI
Arch Pathol Lab Med; 2007 Mar; 131(3):457-67. PubMed ID: 17516749
[TBL] [Abstract][Full Text] [Related]
7. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
8. Absence of ATM deletions in 16 cases of splenic marginal-zone B-cell lymphoma (SMZBCL).
Salido M; Astier L; Puigdecanet E; Espinet B; Florensa L; Solé F
Haematologica; 2003 Nov; 88(11):ELT33. PubMed ID: 14607769
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the ATM gene in T-cell prolymphocytic leukemias.
Stoppa-Lyonnet D; Soulier J; Laugé A; Dastot H; Garand R; Sigaux F; Stern MH
Blood; 1998 May; 91(10):3920-6. PubMed ID: 9573030
[TBL] [Abstract][Full Text] [Related]
10. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
[TBL] [Abstract][Full Text] [Related]
11. BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5' regulatory region of the BCL-6 gene.
Lossos IS; Warnke R; Levy R
Leukemia; 2002 Sep; 16(9):1857-62. PubMed ID: 12200704
[TBL] [Abstract][Full Text] [Related]
12. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.
Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM
Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185
[TBL] [Abstract][Full Text] [Related]
13. Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Milani R; Bardi A; Minotto C; Agostini P; De Angeli C; Narducci MG; Sabbioni S; Russo G; Negrini M; Castoldi G
J Clin Oncol; 2000 Jul; 18(13):2607-14. PubMed ID: 10893293
[TBL] [Abstract][Full Text] [Related]
14. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
15. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P
Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742
[TBL] [Abstract][Full Text] [Related]
16. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
Fang NY; Greiner TC; Weisenburger DD; Chan WC; Vose JM; Smith LM; Armitage JO; Mayer RA; Pike BL; Collins FS; Hacia JG
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5372-7. PubMed ID: 12697903
[TBL] [Abstract][Full Text] [Related]
18. ATM mutations in B-cell chronic lymphocytic leukemia.
Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
[TBL] [Abstract][Full Text] [Related]
19. ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype.
Babaei M; Mitui M; Olson ER; Gatti RA
Hum Genet; 2005 Jul; 117(2-3):101-6. PubMed ID: 15843990
[TBL] [Abstract][Full Text] [Related]
20. CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas.
Tort F; Hernàndez S; Beà S; Martínez A; Esteller M; Herman JG; Puig X; Camacho E; Sánchez M; Nayach I; Lopez-Guillermo A; Fernández PL; Colomer D; Hernàndez L; Campo E
Blood; 2002 Dec; 100(13):4602-8. PubMed ID: 12393693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
